1. Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia
- Author
-
Na-Qiong Wu, Yuan-Lin Guo, Qian Dong, Ming-Ming Liu, Ying Gao, Cheng-Gang Zhu, Jian-Jun Li, and Jia Peng
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Epidemiology ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Lower risk ,Severity of Illness Index ,Hyperlipoproteinemia Type II ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,030212 general & internal medicine ,Myocardial infarction ,Risk factor ,Stroke ,Proportional hazards model ,business.industry ,Hazard ratio ,Coronary Stenosis ,nutritional and metabolic diseases ,medicine.disease ,Diabetes Mellitus, Type 2 ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Aims Type 2 diabetes mellitus (T2DM) is an independent risk factor for cardiovascular disease. However, the association between T2DM and coronary artery disease (CAD) in patients with heterozygous familial hypercholesterolaemia (HeFH) has not been thoroughly evaluated. Our study aimed to assess the effect of T2DM on CAD severity and hard cardiovascular endpoints in a HeFH cohort. Methods and results A total of 432 patients with HeFH with a molecular and/or clinical Dutch Lipid Clinic Network score ≥6 (definite and probable) were enrolled. Patients were divided into a T2DM group (n = 99) and a non-T2DM group (n = 333). The severity of coronary stenosis was assessed by the number of diseased vessels and Gensini, SYNTAX, and Jeopardy scores. Hard endpoints included a composite of non-fatal myocardial infarction, non-fatal stroke, and cardiac death. Cox regression and Kaplan–Meier analyses were used to evaluate the effect of T2DM on hard cardiovascular endpoints. The prevalence of CAD was higher in patients with T2DM compared with those without (96.0% vs. 77.5%, respectively; P Conclusion We conclude that T2DM is an independent predictor of CAD severity when assessed by number of diseased vessels, Gensini, SYNTAX, Jeopardy scores, and hard cardiovascular endpoints, suggesting that T2DM could be further used for risk stratification of patients with HeFH.
- Published
- 2021
- Full Text
- View/download PDF